MyFinsight
Home
Blog
About
Contact
Download
Download image
Comprehensive loss
-$39,097K
Unrealized gain on
available-for-sale securities
-$47K
Net loss
-$38,626K
Provision for pension
benefit obligation
-$518K
Income tax benefit
(provision)
-$1,097K
Interest income
$12,942K
Foreign currency
exchange gain, net
$1,484K
Gain on disposal of
fixed assets
$59K
Net loss before
income taxes
-$39,723K
Total other income
$14,485K
Loss from operations
-$54,208K
Collaboration revenue
$123,672K
Total operating
expenses
$177,880K
Research and development
$141,500K
General and
administrative
$36,380K
Back
Back
Income Statement
source: myfinsight.com
Monte Rosa Therapeutics, Inc. (GLUE)
Monte Rosa Therapeutics, Inc. (GLUE)